PureTech Health (PRTC) EPS (Basic) (2024 - 2025)
PureTech Health (PRTC) reported EPS (Basic) of -$9.18 for Q2 2025, down 5490.68% on a QoQ basis from -$0.16 in Q4 2024.
PureTech Health (PRTC) has 2 years of EPS (Basic) data on file, last reported at -$9.18 in Q2 2025.
- Quarterly EPS (Basic) changed N/A year-over-year to -$9.18 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$9.34 (down 5590.68% YoY) and the FY2025 annual result came in at -$0.46, down 319.05% from the prior year.
- EPS (Basic) fell to -$9.18 in Q2 2025 per PRTC's latest filing, from -$0.16 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.16 in Q4 2024 and bottomed at -$9.18 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -9.18 |
| Dec 31, 2024 | -0.16 |